Monday, June 15, 2026

How Huons and Sanofi’s Vaccine Partnership Will Transform the Korean Market in 2026

Huons partners with Sanofi to distribute five vaccines in South Korea, enhancing access and leveraging cold chain logistics for better healthcare.

PACIFIC DEFENSE COLLAPSE : The Mad Dictator’s Golden Opportunity As THAAD Vanishes To The Middle East

U.S. concerns rise over THAAD redeployment from South Korea to the Middle East amid North Korea's threats, questioning defense readiness.

Boryung Begins First Global CDMO Supply of Alimta Through Taiwan Partnership

Boryung Pharmaceutical starts supplying Alimta to Lotus, enhancing global CDMO efforts and addressing chemotherapy drug shortages.

Tag: profit

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

PharmaResearch Posts Near-40% Operating Margin as Rejuran and Medical Aesthetics Drive Growth

PharmaResearch reports a 39.2% operating profit margin, driven by strong sales in medical aesthetics and cosmetics, despite market competition.

GC MediAI Issues First Profit Guidance Since Founding, Targeting 80% Operating Profit Growth

GC MediAI forecasts 13.5 billion KRW profit in 2026, driven by AI and platform growth, with strong performance in medical sectors.

Wontec’s Bold Move: 6 Billion KRW Buyback to Boost Shareholder Value in 2026

Wontech plans to repurchase shares worth 6 billion KRW to boost shareholder value and confidence, aiming for strong growth by 2025.

How Vieworks Plans to Boost Shareholder Value with 12.4% Dividend Increase in 2026

Vieworks plans to enhance corporate value through growth strategies, increased dividends, and share buybacks to boost shareholder returns.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

Ubicare Targets 80%+ Operating Profit Growth in 2026 — Here’s What’s Changing in Its EMR and Platform Play

Ubicare reported a 46% increase in operating profit for 2025, driven by optimized revenue structures and plans for AI solutions in 2026.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

BYD Becomes First EV Giant to Break $100B Revenue Mark

BYD surpasses $100 billion in annual revenue, overtaking Tesla as the first EV company to achieve this milestone.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.